Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

OPRX stock hub

OptimizeRx Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OPRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

120.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

OPRX

In the news

Latest news · OPRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.8

P25 12.3P50 18.4P75 33.1

Trailing P/E23.9

P25 14.9P50 23.2P75 38.5

ROE4.2

P25 -105.6P50 -46.5P75 -3.1

ROIC6.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OPRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

245

Groups with data

Currency

USD

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001448431
Company name	OptimizeRx Corporation
Country	United States
Country code	US
Cusip	68401U204
Employees	133
Employees Change	4%
Employees Change Percent	3.1
Enterprise value	$123.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
Isin	US68401U2042
Last refreshed	2026-05-10
Market cap	$120.8M
Market cap category	Micro-Cap
Price	$6.44
Price currency	USD
Rev Per Employee	822,774.44x
Sector	Healthcare
Sic	7389
Symbol	OPRX
Website	https://www.optimizerx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.25%
EV Earnings	24.08x
EV Sales Forward	1.09x
EV/EBIT	10.25x
EV/EBITDA	7.54x
EV/FCF	6.62x
EV/Sales	1.13x
FCF yield	15.44%
Forward P/E	6.84x
P/B ratio	0.94x
P/E ratio	23.85x
P/S ratio	1.1x
PS Forward	1.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.02%
EBITDA Margin	14.98%
FCF margin	17.05%
Gross margin	67.25%
Gross Profit	$73.6M
Gross Profit Growth	23.94%
Gross Profit Growth Q	9.43%
Gross Profit Growth3 Y	23.61%
Gross Profit Growth5 Y	25.01%
Net Income	$5.1M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Pretax Margin	6.35%
Profit Margin	4.69%
Profit Per Employee	$38,586
Profitable Years	1
ROA	4.33
Roa5y	-1.67
ROCE	7.75
ROE	4.18
Roe5y	-6.94
ROIC	6.79
Roic5y	-6.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.41%
Cagr15y	5.09%
Cagr1y	-32.09%
Cagr20y	-22.67%
Cagr3y	-23.66%
Cagr5y	-34.25%
EPS Growth Years	1
FCF Growth	290.56%
FCF Growth Q	3,809.95%
FCF Growth3 Y	20.84%
OCF Growth	282.8%
OCF Growth Q	3,479.8%
OCF Growth10 Y	43.23%
OCF Growth3 Y	20.66%
Revenue Growth	18.78x
Revenue Growth Q	-0.24x
Revenue Growth Years	16x
Revenue Growth3 Y	20.56x
Revenue Growth5 Y	20.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.63
Assets	$176.9M
Cash	$23.4M
Current Assets	$64.7M
Current Liabilities	$21.3M
Debt	$26.1M
Debt EBITDA	$1.57
Debt Equity	$0.2
Debt FCF	$1.4
Equity	$128.3M
Interest Coverage	2.28
Liabilities	$48.6M
Long Term Assets	$112.2M
Long Term Liabilities	$27.4M
Net Cash	$-2.7M
Net Cash By Market Cap	$-2.27
Net Debt EBITDA	$0.17
Net Debt Equity	$0.02
Net Debt FCF	$0.15
Tangible Book Value	$16.6M
Tangible Book Value Per Share	$0.89
WACC	11.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.04
Net Working Capital	$24.5M
Quick ratio	2.91
Working Capital	$43.5M
Working Capital Turnover	$2.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.86%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	104.44%
1Y total return	-32.07%
200-day SMA	12.95
3Y total return	-55.52%
50-day SMA	6.63
50-day SMA vs 200-day SMA	50under200
5Y total return	-87.71%
All Time High	6,000.1
All Time High Change	-99.89%
All Time High Date	2006-12-18
All Time Low	0.6
All Time Low Change	973.33%
All Time Low Date	2009-09-24
ATR	0.46
Beta	1.19
Beta1y	2.81
Beta2y	1.95
Ch YTD	-47.47
High	6.57
High52	22.25
High52 Date	2025-10-27
High52ch	-71.06%
Low	6.3
Low52	5.54
Low52 Date	2026-03-06
Low52ch	16.25%
Ma50ch	-2.81%
Premarket Change Percent	-0.15
Premarket Price	$6.62
Premarket Volume	5,997
Price vs 200-day SMA	-50.28%
RSI	46.5
RSI Monthly	39.74
RSI Weekly	33.03
Sharpe ratio	-0.16x
Sortino ratio	-0.16
Total Return	-3.86%
Tr YTD	-47.47
Tr15y	110.46%
Tr1m	-3.16%
Tr1w	-3.88%
Tr3m	-40.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	18,372,400x
Earnings Revenue Estimate Growth	-16.21x
Operating Income	$12.1M
Operating Income Growth Q	130.5
Operating margin	11.02
Price target	$16.67
Price Target Change	$159

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,470,325%
Float Percent	77.12%
Net Borrowing	-8,000,000
Shares Insiders	14.84%
Shares Institutions	71.09%
Shares Out	18,762,203
Shares Qo Q	-0.41%
Shares Yo Y	3.86%
Short Float	14.94%
Short Ratio	4.22
Short Shares	11.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$11.7M
Average Volume	409,110.25x
Bv Per Share	6.84
CAPEX	$-58,000
Ch10y	104.4
Ch15y	110.5
Ch1m	-3.16
Ch1w	-3.88
Ch1y	-32.07
Ch20y	-99.41
Ch3m	-40.86
Ch3y	-55.52
Ch5y	-87.71
Ch6m	-58.85
Change	-2.87%
Change From Open	-1.98
Close	6.63
Days Gap	-0.9
Depreciation Amortization	4,327,000
Dollar Volume	1,496,784.8
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$12.1M
EBITDA	$16.4M
EPS	$0.27
F Score	8
FCF	$18.7M
FCF EV Yield	15.1x
FCF Per Share	$0.99
Financing CF	-8,798,000
Fiscal Year End	December
Founded	2,006
Goodwill	70,869,000
Graham Number	6.44561
Graham Upside	0.09
Income Tax	$1.8M
Investing CF	68,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Date	2018-05-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	11.68
Ma150ch	-44.86%
Ma20	6.54
Ma20ch	-1.51%
Net CF	9,985,000
Next Earnings Date	2026-05-12
Open	6.57
Optionable	Yes
P FCF Ratio	6.48
P OCF Ratio	6.46
Position In Range	51.85
Post Close	6.44
Postmarket Change Percent	-0.54
Postmarket Price	$6.41
Ppne	510,000
Pre Close	6.63
Price Date	2026-05-08
Price EBITDA	$7.37
Ptbv Ratio	7.27
Relative Volume	0.57x
Revenue	109,429,000x
SBC By Revenue	6.36x
Share Based Comp	6,962,000
Tax By Revenue	1.66x
Tax Rate	26.16%
Tr20y	-99.41%
Tr6m	-58.85%
Us State	Massachusetts
Volume	232,420
Z Score	3.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OPRX pay a dividend?

Capital-return profile for this ticker.

Performance

OPRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OPRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+71.1%

Float: +77.1% of shares outstanding

Insider ownership

+14.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OPRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.5

Neutral momentum band

Price vs 200-day MA

-50.3%

50/200-day relationship not available

Beta (5Y)

1.19

Moves roughly with the market

Sharpe ratio

-0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OPRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OPRX stock rating?

OptimizeRx Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OPRX analysis?

The full report lives at /stocks/OPRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OPRX?

The latest report frames OPRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OPRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.